Research by Ouerhani et al., (2011) investigated the association between xenobiotic metabolizing gene polymorphisms and susceptibility to AML, CML, CLL, and ALL in the Tunisian population, and found that NAT2 polymorphisms do not influence either predisposition or prognosis in CML patients. This evidence concerns the gene NAT2 and acute myeloid leukemia.